Terry Furlong - Concepedia

Author

Terry Furlong

Fred Hutch Cancer Center

Also Known As

Terry Furlong

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa Cancer Research Center The University of Texas MD Anderson Cancer Center

About

Terry Furlong is an author at Fred Hutch Cancer Center specializing in pharmacotherapy, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	21
2	Immunology	1	1	21
3	Pharmacology	1	1	21
4	Drug Discovery	1	1	21
5	Hematology	1	1	21

Terry Furlong

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong, Journal of Clinical Oncology	2014	271
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation Marco Mielcarek, Terry Furlong, Paul V. O’Donnell, Blood	2016	225
SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1 Ana Benito, Terry Furlong, Paul J. Martin, Transplantation	2001	182
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes Marco Mielcarek, Barry E. Storer, Michael Boeckh, Blood	2008	136
A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation Richard A. Nash, Laura Johnston, Pablo Parker, Biology of Blood and Marrow Transplantation	2005	124
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide Christopher G. Kanakry, Javier Bolaños‐Meade, Yvette L. Kasamon, Blood	2017	88
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease Terry Furlong, Wendy M. Leisenring, Rainer Storb, Biology of Blood and Marrow Transplantation	2002	62
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease Fabrizio Carnevale‐Schianca, Paul J. Martin, Keith M. Sullivan, Biology of Blood and Marrow Transplantation	2000	54
Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Prevention of Graft-versus-Host Disease following Hematopoietic Cell Transplantation from Unrelated Donors Terry Furlong, Hans‐Peter Kiem, Frederick R. Appelbaum, Biology of Blood and Marrow Transplantation	2008	47
A Retrospective Comparison of Tacrolimus versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation with Mobilized Blood Cells Yoshihiro Inamoto, Mary E.D. Flowers, Frederick R. Appelbaum, Biology of Blood and Marrow Transplantation	2011	42

Page 1